Development of peptide receptor binding assays: methods to avoid false negatives

Valentijn Vergote1, Sylvia Van Dorpe, Mathieu Verbeken

  • 1Drug Quality and Registration (DruQuaR) group, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium.

Regulatory Peptides
|August 27, 2009
PubMed
Summary

Optimizing peptide ligand receptor binding assays is crucial. This study developed a cost-effective multivariate screening method to identify optimal conditions, minimizing false negative results in peptide binding studies.

Related Concept Videos